297 related articles for article (PubMed ID: 16430886)
1. Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics.
Mottier L; Alvarez L; Ceballos L; Lanusse C
Exp Parasitol; 2006 May; 113(1):49-57. PubMed ID: 16430886
[TBL] [Abstract][Full Text] [Related]
2. Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni: correlation with their octanol-water partition coefficients.
Mottier ML; Alvarez LI; Pis MA; Lanusse CE
Exp Parasitol; 2003; 103(1-2):1-7. PubMed ID: 12810040
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium.
Alvarez LI; Mottier ML; Lanusse CE
Parasitology; 2004 Jan; 128(Pt 1):73-81. PubMed ID: 15002906
[TBL] [Abstract][Full Text] [Related]
4. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.
Mottier L; Alvarez L; Fairweather I; Lanusse C
J Parasitol; 2006 Dec; 92(6):1355-60. PubMed ID: 17304820
[TBL] [Abstract][Full Text] [Related]
5. Measurement of triclabendazole and its metabolites in liver flukes: method development and full validation.
Mottier L; Moreno L; Alvarez L; Virkel G; Lanusse C
J Pharm Biomed Anal; 2004 Sep; 35(5):991-9. PubMed ID: 15336346
[TBL] [Abstract][Full Text] [Related]
6. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
Alvarez LI; Solana HD; Mottier ML; Virkel GL; Fairweather I; Lanusse CE
Parasitology; 2005 Oct; 131(Pt 4):501-10. PubMed ID: 16174415
[TBL] [Abstract][Full Text] [Related]
7. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective binding of albendazole sulphoxide to cytosolic proteins from helminth parasites.
Solana HD; Sallovitz JM; Lanusse CE; Rodriguez JA
Methods Find Exp Clin Pharmacol; 2002; 24(1):7-13. PubMed ID: 11980387
[TBL] [Abstract][Full Text] [Related]
9. Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites.
Solana HD; Rodriguez JA; Lanusse CE
Parasitol Res; 2001 Apr; 87(4):275-80. PubMed ID: 11355675
[TBL] [Abstract][Full Text] [Related]
10. Drug transfer into target helminth parasites.
Alvarez LI; Mottier ML; Lanusse CE
Trends Parasitol; 2007 Mar; 23(3):97-104. PubMed ID: 17236810
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica.
Alvarez LI; Mottier ML; Sánchez SF; Lanusse CE
Parasitol Res; 2001 Nov; 87(11):929-34. PubMed ID: 11728018
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep.
Virkel G; Lifschitz A; Sallovitz J; Pis A; Lanusse C
J Vet Pharmacol Ther; 2006 Jun; 29(3):213-23. PubMed ID: 16669866
[TBL] [Abstract][Full Text] [Related]
13. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
[TBL] [Abstract][Full Text] [Related]
14. Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica.
Mottier L; Virkel G; Solana H; Alvarez L; Salles J; Lanusse C
Xenobiotica; 2004; 34(11-12):1043-57. PubMed ID: 15801547
[TBL] [Abstract][Full Text] [Related]
15. Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability.
Moreno L; Alvarez L; Mottier L; Virkel G; Bruni SS; Lanusse C
J Vet Pharmacol Ther; 2004 Oct; 27(5):299-308. PubMed ID: 15500567
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
[TBL] [Abstract][Full Text] [Related]
17. A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.
Toner E; McConvery F; Brennan GP; Meaney M; Fairweather I
Parasitology; 2009 Apr; 136(5):523-35. PubMed ID: 19272211
[TBL] [Abstract][Full Text] [Related]
18. Understanding the main route of drug entry in adult Fasciola hepatica: Further insights into closantel pharmacological activity.
Ceballos L; Canton C; Cadenazzi G; Larsen K; Virkel G; Moreno L; Fairweather I; Lanusse C; Alvarez L
Exp Parasitol; 2017 Oct; 181():23-29. PubMed ID: 28734749
[TBL] [Abstract][Full Text] [Related]
19. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
Robinson MW; Lawson J; Trudgett A; Hoey EM; Fairweather I
Parasitol Res; 2004 Feb; 92(3):205-10. PubMed ID: 14652740
[TBL] [Abstract][Full Text] [Related]
20. A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.
Toner E; Brennan GP; McConvery F; Meaney M; Fairweather I
Parasitology; 2010 Apr; 137(5):855-70. PubMed ID: 20030907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
